Halidou Tinto

Halidou Tinto is Regional Director of the Institute for Health Sciences Research (IRSS) and Head of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso. Since 2016, he has served as Associate Professor at the Faculty of Medicine, Nazi Boni University of Bobo-Dioulasso, where he teaches clinical trials in the Master Program. His research spans malaria vaccine development, antimicrobial phytomedicines, and infectious disease management.

Education includes:

• PhD in Medical Sciences, University of Antwerp (2006)
• Certificate in Epidemiology & Statistics, Université Libre de Bruxelles (2005)
• Diploma in Clinical Research, Vienna School of Clinical Research (2005)
• PharmD, University of Mali (1998)
• Advanced Studies in Biochemistry/Microbiology, Université de Ouagadougou (1998)

Research focuses on clinical trial implementation (including GSK's RTS,S and R21 malaria vaccines), evaluation of traditional African medicines like OPIC and Saye for infectious diseases, and antiplasmodial plant studies. Key methodologies include ICH/GCP-standard trials and phytochemical analysis.

Awards and honors:

• 9 scientific recognitions between 2002-2021 including international prizes from France, UK, Canada, and Burkina Faso
• Multiple "Scientist of the Year" and "Man of the Year" designations

Secured major grants as Principal Investigator:

• Pharmaceutical development of OPIC for bacterial/fungal dermatoses (2020-2022)
• Clinical evaluation of antimalarial phytomedicine Saye (2013-2016)
• Anti-microbial activity of Opilia celtidifolia (2013-2017)
• Anti-plasmodial studies of Canthium multiflorum (2008-2009)

Leads the Clinical Research Unit of Nanoro and collaborates with Malaria in Pregnancy Consortium, MalaCtres, Indepth Network, and Malaria Clinical Trial Alliance. Former Scientific Director of Centre Muraz Research Institute.